These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36524477)

  • 1. Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria.
    Galindo RJ; Aleppo G; Parkin CG; Baidal DA; Carlson AL; Cengiz E; Forlenza GP; Kruger DF; Levy C; McGill JB; Umpierrez GE
    J Diabetes Sci Technol; 2024 Jul; 18(4):974-987. PubMed ID: 36524477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring.
    Galindo RJ; Parkin CG; Aleppo G; Carlson AL; Kruger DF; Levy CJ; Umpierrez GE; McGill JB
    Diabetes Technol Ther; 2021 Sep; 23(9):652-660. PubMed ID: 33844588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion.
    Aleppo G; Parkin CG; Carlson AL; Galindo RJ; Kruger DF; Levy CJ; Umpierrez GE; Forlenza GP; McGill JB
    Diabetes Technol Ther; 2021 Oct; 23(10):715-725. PubMed ID: 34077674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Glucose Monitoring (CGM) Is a Tool, Not a Reward: Unjustified Insurance Coverage Criteria Limit Access to CGM.
    Kruger DF; Anderson JE
    Diabetes Technol Ther; 2021 Sep; 23(S3):S45-S55. PubMed ID: 34160300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified.
    Anderson JE; Gavin JR; Kruger DF
    Diabetes Technol Ther; 2020 Mar; 22(3):169-173. PubMed ID: 31596132
    [No Abstract]   [Full Text] [Related]  

  • 6. Addressing healthcare disparities and managed care considerations with continuous glucose monitoring.
    McAdam-Marx C
    Am J Manag Care; 2022 Jul; 28(4 Suppl):S76-S84. PubMed ID: 36007237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy.
    Frank JR; Blissett D; Hellmund R; Virdi N
    Diabetes Technol Ther; 2021 Sep; 23(S3):S36-S44. PubMed ID: 34546079
    [No Abstract]   [Full Text] [Related]  

  • 8. Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations.
    Forlenza GP; Carlson AL; Galindo RJ; Kruger DF; Levy CJ; McGill JB; Umpierrez G; Aleppo G
    Diabetes Technol Ther; 2022 Nov; 24(11):814-823. PubMed ID: 35763323
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
    Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
    J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance.
    Addala A; Maahs DM; Scheinker D; Chertow S; Leverenz B; Prahalad P
    Pediatr Diabetes; 2020 Nov; 21(7):1301-1309. PubMed ID: 32681582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All Children Deserve to Be Safe, Mothers Too: Evidence and Rationale Supporting CGM Use in Gestational Diabetes Within the Medicaid Population.
    Levy CJ; Galindo RJ; Parkin CG; Gillis J; Argento NB
    J Diabetes Sci Technol; 2023 Mar; ():19322968231161317. PubMed ID: 36919680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Continuous Glucose Monitor Receipt and Diabetes Care Provider Type: A Cohort Study of West Virginia Medicaid Beneficiaries With Type 1 Diabetes.
    Gaulke AP; Giordano J; Grossman DS
    Med Care; 2023 Nov; 61(11):760-764. PubMed ID: 37737739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inequity in Adoption of Advanced Diabetes Technologies Among Medicare Fee-for-service Beneficiaries.
    Wherry K; Zhu C; Vigersky RA
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e2177-e2185. PubMed ID: 34910144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Equitable Access to Continuous Glucose Monitors for Alabama's Children with Type 1 Diabetes: A Quality Improvement Project.
    Schmitt J; Fogle K; Scott ML; Iyer P
    Diabetes Technol Ther; 2022 Jul; 24(7):481-491. PubMed ID: 35156834
    [No Abstract]   [Full Text] [Related]  

  • 17. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.
    Fonseca VA; Grunberger G; Anhalt H; Bailey TS; Blevins T; Garg SK; Handelsman Y; Hirsch IB; Orzeck EA; Roberts VL; Tamborlane W;
    Endocr Pract; 2016 Aug; 22(8):1008-21. PubMed ID: 27214060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring Metrics for Pregnancies Complicated by Diabetes: Critical Appraisal of Current Evidence.
    Szmuilowicz ED; Barbour L; Brown FM; Durnwald C; Feig DS; O'Malley G; Polsky S; Aleppo G
    J Diabetes Sci Technol; 2024 Jul; 18(4):819-834. PubMed ID: 38606830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology.
    Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T
    J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming diabetes care with continuous glucose monitoring: Rationale for expanded eligibility criteria.
    Hirsch BR
    J Am Assoc Nurse Pract; 2024 Jul; 36(7):385-390. PubMed ID: 38669198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.